Sernova Corp. (SVA) Receiving Somewhat Positive News Coverage, Study Shows

Media coverage about Sernova Corp. (NASDAQ:SVA) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sernova Corp. earned a news impact score of 0.04 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 45.0744433308972 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the media stories that may have impacted Accern’s rankings:

Separately, BidaskClub upgraded shares of Sernova Corp. from a “hold” rating to a “buy” rating in a research report on Friday, November 3rd.

Shares of Sernova Corp. (NASDAQ SVA) opened at C$7.17 on Friday. Sernova Corp. has a 1 year low of C$4.60 and a 1 year high of C$7.32.

TRADEMARK VIOLATION NOTICE: “Sernova Corp. (SVA) Receiving Somewhat Positive News Coverage, Study Shows” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at

Sernova Corp. Company Profile

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps.

Insider Buying and Selling by Quarter for Sernova Corp. (NASDAQ:SVA)

Receive News & Ratings for Sernova Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Corp. and related companies with's FREE daily email newsletter.

Leave a Reply